Complement inhibitor treatment shows promise for periodontitis
University of Pennsylvania researchers have found a promising new treatment for periodontitis using a component of the immune system called complement, according to a new
University of Pennsylvania researchers have found a promising new treatment for periodontitis using a component of the immune system called complement, according to a new
Doxepin rinse may prove to be an option to help relieve pain associated with oral mucositis in patients with head and neck cancers, according to
Cannabinoids may offer hope for oral cancer pain, according to a presentation at the recent American Pain Society (APS) annual meeting in Tampa, FL. A
Researchers from Finland have discovered a gene mutation in ameloblastoma, an odontogenic tumor with a high tendency to recur after treatment, as reported in the
The U.S. Food and Drug Administration (FDA) has approved a human papillomavirus (HPV) DNA test for women 25 and older that can be used to
The ADA is offering a new oral pathologist app to help dentists diagnose lesions, papules, nodules, ulcers, vesicles, and other oral pathology conditions. The app
Researchers from the Case Western Reserve University have found a new, less invasive method to extract single, rare immune cells from the mouth to study
Researchers have identified a new biomarker linked to better outcomes in patients with head and neck cancer (HNC) and non-small cell lung cancer, according to
A new technique that uses atmospheric pressure plasma, a new radiation source, could be used for dental care and to treat oral cancer, according to
Researchers have demonstrated a method of reversing bone loss and inflammation for patients with leukocyte adhesion deficiency (LAD). Leukocyte adhesion deficiency is a rare but
With the oral-systemic health link now well recognized, this is the time to help patients understand what they need to do to control bacteria at
Byproducts in the form of small-chain fatty acids from two bacteria prevalent in periodontal disease incite the growth of deadly Kaposi’s sarcoma (KS)-related oral lesions